HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP
Clinical trial NCT05883748 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05883748
- Sponsor
- Disc Medicine, Inc
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-31
- Primary completion
- 2028-06-01
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.